IncFact
Company Profiles: Revenue, Growth, Competition

Global Isotopes LLC D/B/A Zevacor Molecular Revenue, Growth & Competitor Profile

DBA GLOBAL ISOTOPES, LLC
DBA GLOBAL ISOTOPES, LLC D/B/A ZEVACOR
DBA ZEVACOR
DBA ZEVACOR MOLECULAR
Last updated:

Company Awards

Fast Growing
Fastest Growing

Company Profile & Annual Report for Global Isotopes LLC D/B/A Zevacor Molecular

Access the complete profile.

Global Isotopes LLC D/B/A Zevacor Molecular Fast Facts

Revenue$10 - $100 million    See Exact Annual Revenue
Employees10 - 100Exact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes325412 Pharmaceutical Preparation Manufacturing
Address14395 Bergen Blvd
Noblesville, IN 46060

Note: Revenues for privately held companies are statistical evaluations.


Global Isotopes LLC D/B/A Zevacor Molecular's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Global Isotopes LLC D/B/A Zevacor Molecular is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Global Isotopes LLC D/B/A Zevacor Molecular Annual Revenue and Growth Rate

Global Isotopes LLC D/B/A Zevacor Molecular Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 $10 - $100 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Global Isotopes LLC D/B/A Zevacor Molecular's revenues are gauged from an analysis of company filings.



Global Isotopes LLC D/B/A Zevacor Molecular's Income Statement (based on Industry Averages)

Global Isotopes LLC D/B/A Zevacor Molecular P&L$ Millions
Revenue (Sales) Global Isotopes LLC D/B/A Zevacor Molecular Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Market Share of Global Isotopes LLC D/B/A Zevacor Molecular's Largest Competitors

A competitive analysis shows these companies are in the same general field as Global Isotopes LLC D/B/A Zevacor Molecular, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
XYMOGENOrlando, FL100 
AVANTI NUTRITIONAL LABORATORIESMiami Lakes, FL37 
NUTRITION FORMULATORSMiramar, FL36 
RTPRCabot, AR33 
INTEGRATED BOTANICSFort Worth, TX29 
COSMAX NBT USAGarland, TX29 
CJB INDUSTRIESValdosta, GA28 
ALTERNATIVE LABORATORIESNaples, FL28 
S&B PHARMAAzusa, CA28 




Nearby Competitors

These companies are similar in business line and location to Global Isotopes LLC D/B/A Zevacor Molecular. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
SEPROCarmel, IN100 
SCHAFER POWDER COATINGWhitestown, IN68 
AMERICAN ULTRAVIOLETLebanon, IN50 
ROYAL INTERPACK MIDWESTWhitestown, IN40 
ITALPOLLINA USAAnderson, IN39 
GLOBAL ISOTOPES LLC D/B/A ZEVACOR MOLECULARNoblesville, IN23 
SPECIFICATION PRODUCTSNoblesville, IN21 
ADVANCED METALWORKING PRACTICESCarmel, IN8 
PARADIGM INDUSTRIESCarmel, IN7 
DMD PHARMACEUTICALSNoblesville, IN3 




Future Competition: Global Isotopes LLC D/B/A Zevacor Molecular's Fastest Growing Competitors

These companies are in the same general field as Global Isotopes LLC D/B/A Zevacor Molecular and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Global Isotopes LLC D/B/A Zevacor Molecular Competitors